ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Dr Reddy's Laboratories sees generic Revlimid, other launches to keep US business firing
The Hyderabad-based drug maker on Friday reported its highest ever revenues, largely driven by generic Revlimid launch during the second quarter of FY23, and partly due to favorable movement of forex rates and rebound of Russia business.
Announcement as on 28 October 2022

Dr Reddy#39;s Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
Dr Reddy#39;s Q2 result: The drugmaker reported a 9% YoY increase in consolidated revenues at Rs 6,305 crore for the reported quarter
Announcement as on 28 October 2022

Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
Dr Reddy's Laboratories Ltd on Friday said its consolidated profit after tax (PAT) for the quarter ended September 30, 2022 was up by 12 per cent at Rs 1,112.80 crore as against Rs 992 crore in the same quarter a year ago. Revenues during the quarter unde
Announcement as on 28 October 2022

Dr Reddy’s Q2 preview: Pharma major likely to report sharp drop in net profit on weak US biz
Dr Reddy’s North American operations will set the tone for the September quarter performance, as likely price erosion will trigger a decline in sales on a year-on-year basis
Announcement as on 27 October 2022

Dr Reddy’s Q2 Preview: High base to play spoilsport, outlook for US, Russia in focus
Dr Reddy’s topline will continue to be aided by sales contributions from the cancer drug Revlimid’s generic. While the overall revenue growth in North America, which makes for 50% of the total sales, is expected to be constrained by price erosion, Indi
Announcement as on 27 October 2022

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 12.89
  • 12Day Average: 13.69
  • 20Day Average: 13.96
  • 50Day Average: 13.59
  • 100Day Average: 13.68
  • 150Day Average: 13.73
  • 200Day Average: 13.8

RDY Indicators & signals

Indicator MACD (12,26,9)

13.45, 13.66, 0.01
Indicator MACD is in negative zone

Indicator ADX (14)

36, 20.51, 43.59
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
16 Thu Jul 2026 12.70 12.66 to 12.85 -0.55% 0.61 times
15 Wed Jul 2026 12.77 12.75 to 12.95 -0.55% 0.68 times
14 Tue Jul 2026 12.84 12.70 to 12.95 -0.62% 0.92 times
13 Mon Jul 2026 12.92 12.92 to 13.27 -2.12% 0.79 times
10 Fri Jul 2026 13.20 13.06 to 13.70 -4.97% 0.95 times
09 Thu Jul 2026 13.89 13.57 to 14.06 -1.63% 1.69 times
08 Wed Jul 2026 14.12 13.85 to 14.59 -3.49% 1.43 times
07 Tue Jul 2026 14.63 14.34 to 14.72 1.88% 1 times
06 Mon Jul 2026 14.36 14.23 to 14.38 -0.14% 0.44 times
02 Thu Jul 2026 14.38 14.16 to 14.48 2.79% 0.8 times
01 Wed Jul 2026 13.99 13.95 to 14.43 -3.45% 1.3 times
30 Tue Jun 2026 14.49 14.45 to 14.70 -2.49% 1.24 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top